Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.

Proto-oncogene Wnt-1



Homo sapiens (Human)
Reviewed-Annotation score: Annotation score: 5 out of 5-Experimental evidence at protein leveli


Ligand for members of the frizzled family of seven transmembrane receptors. In some developmental processes, is also a ligand for the coreceptor RYK, thus triggering Wnt signaling. Probable developmental protein. May be a signaling molecule important in CNS development. Is likely to signal over only few cell diameters. Has a role in osteoblast function and bone development.1 Publication

GO - Molecular functioni

  1. cytokine activity Source: BHF-UCL
  2. frizzled binding Source: BHF-UCL
  3. receptor agonist activity Source: BHF-UCL
  4. transcription regulatory region DNA binding Source: UniProtKB

GO - Biological processi

  1. bone development Source: UniProtKB
  2. branching involved in ureteric bud morphogenesis Source: Ensembl
  3. canonical Wnt signaling pathway Source: BHF-UCL
  4. canonical Wnt signaling pathway involved in negative regulation of apoptotic process Source: BHF-UCL
  5. cell-cell signaling Source: BHF-UCL
  6. cell fate commitment Source: GO_Central
  7. cellular response to peptide hormone stimulus Source: Ensembl
  8. central nervous system morphogenesis Source: BHF-UCL
  9. cerebellum formation Source: BHF-UCL
  10. diencephalon development Source: Ensembl
  11. embryonic axis specification Source: BHF-UCL
  12. forebrain anterior/posterior pattern specification Source: Ensembl
  13. hematopoietic stem cell proliferation Source: Ensembl
  14. hepatocyte differentiation Source: Ensembl
  15. inner ear morphogenesis Source: Ensembl
  16. midbrain development Source: BHF-UCL
  17. midbrain-hindbrain boundary maturation during brain development Source: Ensembl
  18. myoblast fusion Source: Ensembl
  19. negative regulation of BMP signaling pathway Source: AgBase
  20. negative regulation of cell aging Source: BHF-UCL
  21. negative regulation of cell-cell adhesion Source: BHF-UCL
  22. negative regulation of cell-substrate adhesion Source: BHF-UCL
  23. negative regulation of fat cell differentiation Source: BHF-UCL
  24. negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process Source: Ensembl
  25. negative regulation of transforming growth factor beta receptor signaling pathway Source: Ensembl
  26. neuron differentiation Source: GO_Central
  27. neuron fate determination Source: Ensembl
  28. organ regeneration Source: Ensembl
  29. positive regulation of canonical Wnt signaling pathway Source: Reactome
  30. positive regulation of cell proliferation Source: BHF-UCL
  31. positive regulation of dermatome development Source: BHF-UCL
  32. positive regulation of fibroblast proliferation Source: BHF-UCL
  33. positive regulation of insulin-like growth factor receptor signaling pathway Source: BHF-UCL
  34. positive regulation of lamellipodium assembly Source: BHF-UCL
  35. positive regulation of Notch signaling pathway Source: BHF-UCL
  36. positive regulation of protein phosphorylation Source: Ensembl
  37. positive regulation of sequence-specific DNA binding transcription factor activity Source: BHF-UCL
  38. positive regulation of transcription, DNA-templated Source: UniProtKB
  39. positive regulation of transcription from RNA polymerase II promoter Source: Ensembl
  40. response to wounding Source: UniProtKB
  41. signal transduction in response to DNA damage Source: BHF-UCL
  42. Spemann organizer formation Source: BHF-UCL
  43. spinal cord association neuron differentiation Source: Ensembl
  44. T cell differentiation in thymus Source: Ensembl
  45. ubiquitin-dependent SMAD protein catabolic process Source: Ensembl
  46. Wnt signaling pathway Source: BHF-UCL
Complete GO annotation...

Keywords - Molecular functioni

Developmental protein

Keywords - Biological processi

Wnt signaling pathway

Enzyme and pathway databases

ReactomeiREACT_163710. WNT ligand biogenesis and trafficking.
REACT_18372. Class B/2 (Secretin family receptors).
REACT_264034. disassembly of the destruction complex and recruitment of AXIN to the membrane.
REACT_264199. PCP/CE pathway.
REACT_264596. TCF dependent signaling in response to WNT.
REACT_27161. Transcriptional regulation of white adipocyte differentiation.

Names & Taxonomyi

Protein namesi
Recommended name:
Proto-oncogene Wnt-1
Alternative name(s):
Proto-oncogene Int-1 homolog
Gene namesi
OrganismiHomo sapiens (Human)
Taxonomic identifieri9606 [NCBI]
Taxonomic lineageiEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo
ProteomesiUP000005640 Componenti: Chromosome 12

Organism-specific databases

HGNCiHGNC:12774. WNT1.

Subcellular locationi

GO - Cellular componenti

  1. cell surface Source: Ensembl
  2. cytoplasm Source: UniProtKB
  3. endoplasmic reticulum lumen Source: Reactome
  4. extracellular region Source: Reactome
  5. extracellular space Source: GO_Central
  6. Golgi lumen Source: Reactome
  7. plasma membrane Source: Reactome
  8. proteinaceous extracellular matrix Source: UniProtKB-SubCell
Complete GO annotation...

Keywords - Cellular componenti

Extracellular matrix, Secreted

Pathology & Biotechi

Involvement in diseasei

Osteoporosis (OSTEOP)2 Publications

Disease susceptibility is associated with variations affecting the gene represented in this entry.

Disease descriptionA systemic skeletal disorder characterized by decreased bone mass and deterioration of bone microarchitecture without alteration in the composition of bone. The result is fragile bones and an increased risk of fractures, even after minimal trauma. Osteoporosis is a chronic condition of multifactorial etiology and is usually clinically silent until a fracture occurs.

See also OMIM:166710
Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Natural varianti218 – 2181C → G in OSTEOP; reduced capacity to activate canonical WNT signaling. 1 Publication
Natural varianti235 – 2351R → W in OSTEOP; associated with susceptibility to early-onset osteoporosis; completely fails to activate the WNT-regulated beta-catenin signaling cascade. 1 Publication
Osteogenesis imperfecta 15 (OI15)4 Publications

The disease is caused by mutations affecting the gene represented in this entry.

Disease descriptionAn autosomal recessive form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI15 is characterized by early-onset recurrent fractures, bone deformity, significant reduction of bone density, short stature, and, in some patients, blue sclerae. Tooth development and hearing are normal. Learning and developmental delays and brain anomalies have been observed in some patients.

See also OMIM:615220
Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Natural varianti143 – 1431C → F in OI15. 1 Publication
Natural varianti177 – 1771G → C in OI15; completely fails to activate the WNT-regulated beta-catenin signaling cascade. 1 Publication
Natural varianti298 – 2981F → C in OI15. 2 Publications
Natural varianti355 – 3551V → F in OI15. 1 Publication

Keywords - Diseasei

Disease mutation, Osteogenesis imperfecta, Proto-oncogene

Organism-specific databases

MIMi166710. phenotype.
615220. phenotype.
615221. phenotype.
Orphaneti85193. Idiopathic juvenile osteoporosis.
216812. Osteogenesis imperfecta type 3.
216820. Osteogenesis imperfecta type 4.

Polymorphism and mutation databases


PTM / Processingi

Molecule processing

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Signal peptidei1 – 2727Sequence AnalysisAdd
Chaini28 – 370343Proto-oncogene Wnt-1PRO_0000041405Add

Amino acid modifications

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Glycosylationi29 – 291N-linked (GlcNAc...)Sequence Analysis
Disulfide bondi93 ↔ 104By similarity
Disulfide bondi143 ↔ 151By similarity
Disulfide bondi153 ↔ 170By similarity
Disulfide bondi218 ↔ 232By similarity
Disulfide bondi220 ↔ 227By similarity
Lipidationi224 – 2241O-palmitoleyl serine; by PORCNBy similarity
Disulfide bondi315 ↔ 330By similarity
Glycosylationi316 – 3161N-linked (GlcNAc...)Sequence Analysis
Disulfide bondi345 ↔ 360By similarity
Glycosylationi346 – 3461N-linked (GlcNAc...)Sequence Analysis
Disulfide bondi347 ↔ 357By similarity
Disulfide bondi352 ↔ 353By similarity